To view the full version of this video, please tell us more about yourself. »
Watch MDS experts at the 2025 AAMDSIF Bone Marrow Failure Summit translate and discuss the latest science to advance patient outcomes. This session is moderated by Olatoyosi Odenike, MD from The University of Chicago.
Session Topics:
Targeting pre-mRNA splicing in MDS – Salima Benbarche, PhD, Memorial Sloan Kettering
Allogeneic stem cell transplantation in MDS - patient selection and role of geriatric assessment in transplant optimization – Mariam Nawas, MD, University of Chicago
Measurable residual disease assessment in MDS and clinical relevance? – R. Coleman Lindsley, MD, PhD, Dana-Farber
Higher risk MDS – Lessons learned from Phase III trials, and the way forward? - Hetty Carraway, MD, MBA, FACP, Cleveland Clinic